March 26, 2019 / 11:25 PM / 3 months ago

BRIEF-FDA Approves New Oral Drug To Treat Multiple Sclerosis

March 26 (Reuters) - Novartis AG:

* FDA APPROVES NEW ORAL DRUG TO TREAT MULTIPLE SCLEROSIS

* U.S. FDA - APPROVED MAYZENT (SIPONIMOD) TABLETS TO TREAT ADULTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS

* U.S. FDA - FDA GRANTED APPROVAL OF MAYZENT TO NOVARTIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below